Taiyen Biotech Co Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: 0.015x

Taiyen Biotech Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Taiyen Biotech Co Ltd (1737) has a cash flow conversion efficiency ratio of 0.015x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$99.80 Million ≈ $3.14 Million USD) by net assets (NT$6.71 Billion ≈ $211.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Taiyen Biotech Co Ltd (2003–2025)

Cash flow conversion efficiency of Taiyen Biotech Co Ltd from 2003 to 2025. This chart illustrates how Taiyen Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Taiyen Biotech Co Ltd for real-time trading data and today's change.

Taiyen Biotech Co Ltd Cash Flow Conversion Ratio Explained

Taiyen Biotech Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Taiyen Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Taiyen Biotech Co Ltd ranked by their cash flow conversion efficiency. Also see 1737 market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
TBI Motion Technology Co Ltd TW:4540	-0.091x
Ard Grup Bilisim Teknolojileri AS IS:ARDYZ	0.044x
Oceanhawk Acquisition Corp. Class A Ordinary Shares NASDAQ:OHAC	-0.003x
Phu Nhuan Jewelry JSC VN:PNJ	-0.127x
Anhui Provincial Architectural Design and Research Institute Co.Ltd. SHE:301167	N/A
JVM Co. Ltd KQ:054950	0.063x
Shih Wei Navigation Co Ltd TW:5608	0.020x
Fiducian Group Ltd AU:FID	0.212x

Annual Cash Flow Conversion Efficiency for Taiyen Biotech Co Ltd (2003–2025)

The table below shows the annual cash flow conversion efficiency of Taiyen Biotech Co Ltd from 2003 to 2025. Review Taiyen Biotech Co Ltd (1737) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$6.81 Billion ≈ $214.67 Million	NT$473.77 Million ≈ $14.93 Million	0.070x	-29.77%
2024-12-31	NT$6.67 Billion ≈ $210.07 Million	NT$660.12 Million ≈ $20.80 Million	0.099x	+42.64%
2023-12-31	NT$6.55 Billion ≈ $206.32 Million	NT$454.54 Million ≈ $14.32 Million	0.069x	-20.37%
2022-12-31	NT$6.66 Billion ≈ $209.89 Million	NT$580.69 Million ≈ $18.29 Million	0.087x	-5.39%
2021-12-31	NT$6.51 Billion ≈ $205.21 Million	NT$600.08 Million ≈ $18.91 Million	0.092x	+72.78%
2020-12-31	NT$6.36 Billion ≈ $200.51 Million	NT$339.36 Million ≈ $10.69 Million	0.053x	-0.82%
2019-12-31	NT$6.15 Billion ≈ $193.85 Million	NT$330.81 Million ≈ $10.42 Million	0.054x	-26.43%
2018-12-31	NT$6.16 Billion ≈ $193.93 Million	NT$449.83 Million ≈ $14.17 Million	0.073x	-27.65%
2017-12-31	NT$6.02 Billion ≈ $189.62 Million	NT$607.87 Million ≈ $19.15 Million	0.101x	+6.43%
2016-12-31	NT$5.99 Billion ≈ $188.60 Million	NT$568.06 Million ≈ $17.90 Million	0.095x	+44.86%
2015-12-31	NT$5.86 Billion ≈ $184.65 Million	NT$383.93 Million ≈ $12.10 Million	0.066x	+2.83%
2014-12-31	NT$5.82 Billion ≈ $183.52 Million	NT$371.06 Million ≈ $11.69 Million	0.064x	+79.77%
2013-12-31	NT$5.73 Billion ≈ $180.67 Million	NT$203.21 Million ≈ $6.40 Million	0.035x	+49.72%
2012-12-31	NT$6.53 Billion ≈ $205.60 Million	NT$154.46 Million ≈ $4.87 Million	0.024x	-36.43%
2011-12-31	NT$6.61 Billion ≈ $208.23 Million	NT$246.09 Million ≈ $7.75 Million	0.037x	-18.56%
2010-12-31	NT$6.58 Billion ≈ $207.34 Million	NT$300.89 Million ≈ $9.48 Million	0.046x	-16.13%
2009-12-31	NT$6.57 Billion ≈ $206.92 Million	NT$358.02 Million ≈ $11.28 Million	0.055x	-16.99%
2008-12-31	NT$6.36 Billion ≈ $200.31 Million	NT$417.51 Million ≈ $13.15 Million	0.066x	+35.05%
2007-12-31	NT$6.63 Billion ≈ $208.94 Million	NT$322.49 Million ≈ $10.16 Million	0.049x	-26.86%
2006-12-31	NT$6.96 Billion ≈ $219.34 Million	NT$462.88 Million ≈ $14.58 Million	0.066x	-20.34%
2005-12-31	NT$6.90 Billion ≈ $217.39 Million	NT$575.91 Million ≈ $18.14 Million	0.083x	-76.90%
2004-12-31	NT$7.85 Billion ≈ $247.21 Million	NT$2.84 Billion ≈ $89.32 Million	0.361x	-22.55%
2003-12-31	NT$7.33 Billion ≈ $230.91 Million	NT$3.42 Billion ≈ $107.73 Million	0.467x	--

About Taiyen Biotech Co Ltd

TW:1737 Taiwan Household & Personal Products

Market Cap

$189.03 Million

NT$6.00 Billion TWD

Market Cap Rank

#16540 Global

#804 in Taiwan

Share Price

NT$30.00

Change (1 day)

-0.33%

52-Week Range

NT$29.30 - NT$32.50

All Time High

NT$37.55